% Expired Patents = 57.1

CIPO Patents = 2

Forward Citations = 128

Loading Chart...

8 inventors (with patents filed for the assignee):

Philip H Coelho (3 out of 45 patents)

Gabriel Alvarado (3 out of 3 patents)

Ronald H Chiarello (2 out of 3 patents)

4. William Busa (1 out of 4 patents)

5. Jonathan Ellis (1 out of 4 patents)

6. Kathy Yokobata (1 out of 2 patents)

7. Wing-Cheong Liu (1 out of 1 patent)

8. Wing Liu (1 out of 1 patent)

9. Michael Lehmicke (9 patents)

7 patents: Sort by Forward Citations

1. 9695394 - Cell separation devices, systems, and methods (2017-07-04),

2. 9599545 - Method for purifying certain cell populations in blood or bone marrow by depleting others (2017-03-21),

3. 8747289 - System for purifying certain cell populations in blood or bone marrow by depleting others (2014-06-10),

4. 7667033 - Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis (2010-02-23),

5. 7534872 - Compositions and methods for the use of FMOC derivatives in DNA/RNA synthesis (2009-05-19),

6. 7183405 - Compositions and methods for labeling oligonucleotides (2007-02-27),

7. 6750357 - Rhodamine-based fluorophores useful as labeling reagents (2004-06-15),

Company Overview

Syngen, Inc. is a leading biotechnology company specializing in synthetic biology and gene editing. Our innovative technologies and platforms enable the development of sustainable solutions for healthcare, agriculture, and environmental challenges. We are committed to advancing the field of genetic engineering to create a better future for all.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#41 in Sacramento, CA

#9,491 in California

#39,879 in US

Sacramento, CA, United States of America

Syngen, Inc.

Forward Citations = 128

8 inventors:

Philip H Coelho (3 out of 45 patents)

Gabriel Alvarado (3 out of 3 patents)

Ronald H Chiarello (2 out of 3 patents)

4. William Busa (1 out of 4 patents)

5. Jonathan Ellis (1 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Syngen, Inc.. Retrieved from https://idiyas.com/company/syngen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]